Back to GetFilings.com



DRAFT

8/11/03

 

 

UNITED STATES SECURITIES AND EXCHANGE COMMISSION

Washington, D.C.  20549

 

FORM 10-Q

 

ý

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended June 30, 2003

 

o

TRANSITION PERIOD PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from                        to                       

 

Commission File Number: 1-12624

 

Syratech Corporation

(Exact name of registrant as specified in its charter)

 

Delaware

 

13-3354944

(State or other jurisdiction
of incorporation or organization)

 

(I.R.S. Employer
Identification No.)

 

 

 

175 McClellan Highway
East Boston, Massachusetts

 

02128-9114

(Address of principal executive office)

 

(Zip Code)

 

 

 

Registrant’s telephone number, including area code - 617-561-2200

 

Indicate by check mark whether the registrant:  (1) has filed all reports required to be filed by Sections 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.   YES o  NO ý

 

Indicate by check mark whether the registrant is an accelerated filer (as defined in Rule 12b-2 of the Act.)   YES o  NO ý

 

Number of Shares of Common Stock, Par Value $0.01 per share, outstanding at June 30, 2003 - 3,784,018

 

 



 

INDEX

 

PART I - FINANCIAL INFORMATION

 

Item 1.

Financial Statements:

 

 

 

Condensed Consolidated Balance Sheets at June 30, 2003 and December 31, 2002

 

 

Condensed Consolidated Statements of Operations for the three and six month periods ended June 30, 2003 and 2002

 

 

Condensed Consolidated Statements of Cash Flows for the six month periods ended June 30, 2003 and 2002

 

 

Notes to Condensed Consolidated Financial Statements

 

Item 2.

Management’s Discussion and Analysis of Financial Condition and Results of Operations

 

Item 3.

Quantitative and Qualitative Disclosures About Market Risk

 

Item 4.

Controls and Procedures

 

PART II - OTHER INFORMATION

 

 

Item 6.

Exhibits and Reports on Form 8-K

 

 

 

Signature

 



 

SYRATECH CORPORATION AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS

(in thousands, except share data)

 

 

 

June 30,
2003

 

December 31,
2002

 

 

 

(Unaudited)

 

 

 

ASSETS

 

 

 

 

 

Current assets:

 

 

 

 

 

Cash and equivalents

 

$

707

 

$

1,399

 

Accounts receivable, net

 

20,719

 

51,582

 

Inventories

 

69,591

 

58,198

 

Deferred income taxes

 

16,264

 

20,649

 

Prepaid expenses and other

 

3,313

 

2,627

 

Assets held for sale

 

 

3,395

 

Total current assets

 

110,594

 

137,850

 

 

 

 

 

 

 

Property, plant and equipment, net

 

37,057

 

59,742

 

Other assets, net

 

3,576

 

5,154

 

Total

 

$

151,227

 

$

202,746

 

 

 

 

 

 

 

LIABILITIES AND STOCKHOLDERS’ EQUITY

 

 

 

 

 

Current liabilities:

 

 

 

 

 

Revolving loan facilities and notes payable

 

$

18,624

 

$

23,383

 

Accounts payable

 

8,849

 

8,107

 

Accrued expenses

 

8,537

 

11,887

 

Accrued interest

 

2,761

 

3,586

 

Accrued compensation

 

1,749

 

3,529

 

Accrued advertising

 

3,188

 

3,945

 

Deferred gain

 

1,420

 

 

Income taxes payable

 

 

32

 

Liabilities held for sale

 

 

645

 

Total current liabilities

 

45,128

 

55,114

 

 

 

 

 

 

 

Long - term debt

 

118,271

 

153,584

 

Deferred income taxes

 

8,434

 

15,434

 

Pension liability

 

2,799

 

2,674

 

Long-term deferred gain

 

3,829

 

 

Commitments and contingencies

 

 

 

 

 

Stockholders’ equity:

 

 

 

 

 

Preferred stock, $.01 par value, 500,000 shares authorized; (25,000 designated as cumulative redeemable preferred stock, 18,000 shares issued and outstanding, liquidation value of $18,000, and includes accrued and unpaid dividends of $18,483 and $16,419 in 2003 and 2002, respectively)

 

36,483

 

34,419

 

Common stock, $.01 par value, 20,000,000 shares authorized; 3,784,018  shares issued and outstanding

 

38

 

38

 

Deficit

 

(63,442

)

(58,392

)

Accumulated other comprehensive loss

 

(313

)

(125

)

Total stockholders’ equity

 

(27,234

)

(24,060

)

Total

 

$

151,227

 

$

202,746

 

 

See notes to consolidated financial statements.

 

1



 

SYRATECH CORPORATION AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)

(in thousands, except per share data)

 

 

 

Three Months
Ended June 30 ,

 

Six Months
Ended June 30 ,

 

 

 

2003

 

2002

 

2003

 

2002

 

 

 

 

 

 

 

 

 

 

 

Net sales

 

$

35,718

 

$

39,040

 

$

76,391

 

$

77,291

 

Cost of sales

 

25,311

 

27,753

 

55,119

 

55,093

 

 

 

 

 

 

 

 

 

 

 

Gross profit

 

10,407

 

11,287

 

21,272

 

22,198

 

 

 

 

 

 

 

 

 

 

 

Selling, general and administrative expenses

 

14,012

 

15,358

 

27,522

 

30,504

 

 

 

 

 

 

 

 

 

 

 

Income (loss) from continuing operations

 

(3,605

)

(4,071

)

(6,250

)

(8,306

)

 

 

 

 

 

 

 

 

 

 

Interest expense

 

(3,910

)

(4,877

)

(8,149

)

(9,788

)

Interest income

 

 

 

1

 

 

Other income (Note 7)

 

406

 

 

9,446

 

1,236

 

Income (loss) from continuing operations before provision (benefit) for income taxes

 

(7,109

)

(8,948

)

(4,952

)

(16,858

)

 

 

 

 

 

 

 

 

 

 

Provision (benefit) for income taxes

 

(2,900

)

(2,265

)

(2,020

)